Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Bouter, Romain Carmeille, C. Gounou, F. Bouvet, Séverine Degrelle, Séverine Degrelle, D. Evain-Brion, D. Evain-Brion, Alain Brisson (2015)
Review: Annexin-A5 and cell membrane repair.Placenta, 36 Suppl 1
F. Tüttelmann, P. Ivanov, C. Dietzel, Ann-Kristin Sofroniou, T. Tsvyatkovska, R. Komsa-Penkova, A. Markoff, P. Wieacker, N. Bogdanova (2013)
Further insights into the role of the annexin A5 M2 haplotype as recurrent pregnancy loss factor, assessing timing of miscarriage and partner risk.Fertility and sterility, 100 5
H. Matsubayashi, T. Arai, S. Izumi, T. Sugi, J. Mcintyre, T. Makino (2001)
Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures.Fertility and sterility, 76 4
V. Gourvas, N. Soulitzis, A. Konstantinidou, Efterpi Dalpa, O. Koukoura, D. Koutroulakis, D. Spandidos, S. Sifakis (2014)
Reduced ANXA5 mRNA and protein expression in pregnancies complicated by preeclampsia.Thrombosis research, 133 3
J. Uzan, M. Carbonnel, Olivier Piconne, R. Asmar, J. Ayoubi (2011)
Pre-eclampsia: pathophysiology, diagnosis, and managementVascular Health and Risk Management, 7
Susan Ozanne, D. Fernandez‐Twinn, C. Hales (2004)
Fetal growth and adult diseases.Seminars in perinatology, 28 1
A. Kolte, L. Bernardi, O. Christiansen, S. Quenby, R. Farquharson, M. Goddijn, M. Stephenson (2014)
Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group.Human reproduction, 30 3
E. Grandone, M. Margaglione (2003)
Inherited thrombophilia and gestational vascular complications.Best practice & research. Clinical haematology, 16 2
S. Sifakis, G. Soufla, O. Koukoura, N. Soulitzis, D. Koutroulakis, N. Maíz, A. Konstantinidou, E. Melissari, D. Spandidos (2010)
Decreased annexin A5 mRNA placental expression in pregnancies complicated by fetal growth restriction.Thrombosis research, 125 4
B. Fauser (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Human reproduction, 19 1
(2013)
Definitions of infertility and recurrent pregnancy loss: a committee opinionFertil Steril, 99
J. Cha, Xiaofei Sun, S. Dey (2012)
Mechanisms of implantation: strategies for successful pregnancyNature Medicine, 18
E. Rey, S. Kahn, M. David, I. Shrier (2003)
Thrombophilic disorders and fetal loss: a meta-analysisThe Lancet, 361
G. Tiscia, D. Colaizzo, E. Chinni, D. Pisanelli, N. Sciannamé, G. Favuzzi, M. Margaglione, E. Grandone (2009)
Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complicationsThrombosis and Haemostasis, 102
E. Chinni, G. Tiscia, D. Colaizzo, P. Vergura, M. Margaglione, E. Grandone (2009)
Annexin V expression in human placenta is influenced by the carriership of the common haplotype M2.Fertility and sterility, 91 3
P. Egerup, A. Kolte, E. Larsen, M. Krog, H. Nielsen, O. Christiansen (2016)
Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?Human reproduction, 31 11
Holly Ford, D. Schust (2009)
Recurrent pregnancy loss: etiology, diagnosis, and therapy.Reviews in obstetrics & gynecology, 2 2
HB Ford (2009)
76Rev Obstet Gynecol, 2
N. Rogenhofer, Laura Engels, N. Bogdanova, F. Tüttelmann, A. Markoff, C. Thaler (2012)
Paternal and maternal carriage of the annexin A5 M2 haplotype are equal risk factors for recurrent pregnancy loss: a pilot study.Fertility and sterility, 98 2
S. Chernausek (2012)
Update: consequences of abnormal fetal growth.The Journal of clinical endocrinology and metabolism, 97 3
A. Markoff, S. Gerdes, S. Feldner, N. Bogdanova, V. Gerke, E. Grandone (2010)
Reduced allele specific annexin A5 mRNA levels in placentas carrying the M2/ANXA5 allele.Placenta, 31 10
S. Ota, H. Miyamura, H. Nishizawa, H. Inagaki, A. Inagaki, H. Inuzuka, M. Suzuki, J. Miyazaki, T. Sekiya, Y. Udagawa, H. Kurahashi (2013)
Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsia.Placenta, 34 12
D. Branch, T. Porter, L. Rittenhouse, S. Caritis, B. Sibai, B. Hogg, M. Lindheimer, M. Klebanoff, C. Macpherson, J. Vandorsten, M. Landon, Richard Paul, M. Miodovnik, P. Meis, G. Thurnau (2001)
Antiphospholipid antibodies in women at risk for preeclampsia.American journal of obstetrics and gynecology, 184 5
B. Huppertz (2011)
Placental pathology in pregnancy complications.Thrombosis research, 127 Suppl 3
S. Fishel, Deborah Baker, J. Elson, M. Ragunath, G. Atkinson, A. Shaker, Ahmed Omar, Rahnuma Kazem, Ashley Beccles, I. Greer (2016)
Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy OutcomeEBioMedicine, 10
H. Miyamura, H. Nishizawa, S. Ota, Machiko Suzuki, A. Inagaki, H. Egusa, S. Nishiyama, Takema Kato, K. Pryor-Koishi, Isao Nakanishi, T. Fujita, Y. Imayoshi, A. Markoff, I. Yanagihara, Y. Udagawa, H. Kurahashi (2011)
Polymorphisms in the annexin A5 gene promoter in Japanese women with recurrent pregnancy loss.Molecular human reproduction, 17 7
M. Kovo, L. Schreiber, J. Bar (2013)
Placental vascular pathology as a mechanism of disease in pregnancy complications.Thrombosis research, 131 Suppl 1
D. Corach, O. Lao, Cecilia Bobillo, K. Gaag, S. Zuniga, Mark Vermeulen, K. Duijn, M. Goedbloed, P. Vallone, W. Parson, P. Knijff, M. Kayser (2010)
Inferring Continental Ancestry of Argentineans from Autosomal, Y‐Chromosomal and Mitochondrial DNAAnnals of Human Genetics, 74
S. Miyakis, M. Lockshin, T. Atsumi, D. Branch, R. Brey, R. Cervera, R. Derksen, P. Groot, T. Koike, P. Meroni, G. Reber, Y. Shoenfeld, A. Tincani, P. Vlachoyiannopoulos, S. Krilis (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 4
J. Rand, Xiao-Xuan Wu, S. Guller, J. Gil, A. Guha, J. Scher, Charles Lockwood (1994)
Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion.American journal of obstetrics and gynecology, 171 6
Harry Andrees, Marc Stuart, Wim Hermenss, Chris Reutelingspergerll, H. Hemkern, Peter Frederikp, George Willemss (1992)
Clustering of lipid-bound annexin V may explain its anticoagulant effect.The Journal of biological chemistry, 267 25
S. Avena, M. Via, E. Ziv, E. Perez-stable, Christopher Gignoux, C. Dejean, S. Huntsman, G. Torres-Mejía, J. Dutil, J. Matta, K. Beckman, E. Burchard, M. Parolin, A. Goicoechea, N. Acreche, M. Boquet, M. Part, Vanesa Fernández, J. Rey, M. Stern, R. Carnese, L. Fejerman (2012)
Heterogeneity in Genetic Admixture across Different Regions of ArgentinaPLoS ONE, 7
A. Hamza, G. Meyberg-Solomayer, I. Juhasz-Böss, R. Joukhadar, Z. Takacs, E. Solomayer, S. Baum, J. Radosa, L. Mavrova, D. Herr (2016)
Diagnostic Methods of Ectopic Pregnancy and Early Pregnancy Loss: a Review of the LiteratureGeburtshilfe und Frauenheilkunde, 76
E. Alexander, E. Pearce, G. Brent, Rosalind Brown, Herbert Chen, C. Dosiou, W. Grobman, P. Laurberg, J. Lazarus, S. Mandel, R. Peeters, Scott Sullivan (2011)
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.Thyroid : official journal of the American Thyroid Association, 27 3
E. Larsen, O. Christiansen, A. Kolte, N. Macklon (2013)
New insights into mechanisms behind miscarriageBMC Medicine, 11
D. Dizon-Townson, Lesa Nelson, K. Easton, K. Ward (1996)
The factor V Leiden mutation may predispose women to severe preeclampsia.American journal of obstetrics and gynecology, 175 4 Pt 1
H. Ueki, Tomona Mizushina, T. Laoharatchatathanin, Ryota Terashima, Yasuhiro Nishimura, Duangjai Rieanrakwong, T. Yonezawa, S. Kurusu, Y. Hasegawa, B. Brachvogel, E. Pöschl, M. Kawaminami (2012)
Loss of Maternal Annexin A5 Increases the Likelihood of Placental Platelet Thrombosis and Foetal LossScientific Reports, 2
M. Catelli, V. Álvarez-Iglesias, A. Gómez-Carballa, A. Mosquera‐Miguel, C. Romanini, Alicia Borosky, J. Amigo, Á. Carracedo, C. Vullo, A. Salas (2011)
The impact of modern migrations on present-day multi-ethnic Argentina as recorded on the mitochondrial DNA genomeBMC Genetics, 12
G. Tiscia, D. Colaizzo, G. Favuzzi, P. Vergura, P. Martinelli, M. Margaglione, E. Grandone (2012)
The M2 haplotype in the ANXA5 gene is an independent risk factor for idiopathic small-for-gestational age newborns.Molecular human reproduction, 18 10
J. Homburger, A. Moreno-Estrada, Christopher Gignoux, Dominic Nelson, E. Sánchez, Patricia Ortiz-Tello, B. Pons-Estel, E. Acevedo-Vásquez, P. Miranda, C. Langefeld, S. Gravel, M. Alarcón-Riquelme, C. Bustamante (2015)
Genomic Insights into the Ancestry and Demographic History of South AmericaPLoS Genetics, 11
G. Krikun, Charles Lockwood, Xiao-Xuan Wu, Xiaodong Zhou, S. Guller, C. Calandri, A. Guha, Y. Nemerson, J. Rand (1994)
The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation.Placenta, 15 6
M. Kupferminc, A. Eldor, N. Steinman, A. Many, A. Bar-am, A. Jaffa, G. Fait, J. Lessing (1999)
Increased frequency of genetic thrombophilia in women with complications of pregnancy.The New England journal of medicine, 340 1
S. Middeldorp (2007)
Pregnancy failure and heritable thrombophilia.Seminars in hematology, 44 2
N. Bogdanova, J. Horst, M. Chlystun, P. Croucher, A. Nebel, A. Bohring, A. Todorova, S. Schreiber, V. Gerke, M. Krawczak, A. Markoff (2007)
A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss.Human molecular genetics, 16 5
Tang Hock, N. Bogdanova, Ang Cheen, Sushilnathan Kathirgamanathan, Ridzuan Abdullah, Narazah Yusoff, Wan Abdullah, Faizatul Manaf, P. Wieacker, A. Markoff (2015)
M2/ANXA5 haplotype as a predisposition factor in Malay women and couples experiencing recurrent spontaneous abortion: a pilot study.Reproductive biomedicine online, 30 4
(2010)
Haemostatic reference intervals in pregnancy
M. Tikkanen (2011)
Placental abruption: epidemiology, risk factors and consequencesActa Obstetricia et Gynecologica Scandinavica, 90
J. Rand, Xiao-Xuan Wu (2004)
Antibody-mediated interference with annexins in the antiphospholipid syndrome.Thrombosis research, 114 5-6
C. Demetriou, S. Abu-Amero, S. White, E. Peskett, A. Markoff, P. Stanier, G. Moore, L. Regan (2015)
Investigation of the Annexin A5 M2 haplotype in 500 white European couples who have experienced recurrent spontaneous abortion.Reproductive biomedicine online, 31 5
Tracy Dudding, Jon Heron, A. Thakkinstian, A. Thakkinstian, Eha Nurk, Jean Golding, M. Pembrey, M. Pembrey, Susan Ring, John Attia, John Attia, Rodney Scott, Rodney Scott (2008)
Factor V Leiden is associated with pre‐eclampsia but not with fetal growth restriction: a genetic association study and meta‐analysisJournal of Thrombosis and Haemostasis, 6
J. Unterscheider, S. Daly, M. Geary, M. Kennelly, F. Mcauliffe, K. O'Donoghue, A. Hunter, J. Morrison, G. Burke, P. Dicker, Elizabeth Tully, F. Malone (2013)
Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study.American journal of obstetrics and gynecology, 208 4
M. Rodger, M. Betancourt, P. Clark, P. Lindqvist, D. Dizon-Townson, J. Said, U. Seligsohn, M. Carrier, O. Salomon, I. Greer (2010)
The Association of Factor V Leiden and Prothrombin Gene Mutation and Placenta-Mediated Pregnancy Complications: A Systematic Review and Meta-analysis of Prospective Cohort StudiesPLoS Medicine, 7
C. Heuser, J. Dalton, C. Macpherson, D. Branch, T. Porter, R. Silver (2010)
Idiopathic recurrent pregnancy loss recurs at similar gestational ages.American journal of obstetrics and gynecology, 203 4
D. Roberts, M. Post (2008)
The placenta in pre-eclampsia and intrauterine growth restrictionJournal of Clinical Pathology, 61
Purpose Annexin A5 (ANXA5) is a protein abundantly expressed in normal placenta where it contributes to the healthy outcome of a pregnancy. Lower ANXA5 levels have been observed in M2/ANXA5 haplotype carrying chorion. Consequently, this study aimed to assess the potential association of M2 maternal carrier status with the risk of recurrent pregnancy loss (RPL), the timing of miscarriages, and other obstetric complications, for the first time in a population from Latin America. Methods This study was designed as a prospective recruitment of RPL patients with post hoc analysis. The distribution of the M2/ANXA5 haplotype was compared between a group of 229 Argentine women with RPL and 100 parous controls, and was further analyzed in subgroups of patients stratified according to the timing of miscarriages and in relation to other obstetric complications. Results No significant differences were found in the distribution of M2 haplotype among either RPL patients or the subgroups with embryonic, early fetal, or late fetal losses compared to parous controls. Notwithstanding, maternal M2/ANXA5 was found to be independently associated with a higher risk of suffering intrauterine growth restriction (IUGR) and/or preeclampsia (PE). Simultaneously, the presence of inherited and/or acquired thrombophilia also proved to be an independent
Journal of Assisted Reproduction and Genetics – Springer Journals
Published: Mar 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.